DE602004029698D1 - Verfahren zur untersuchung von kolonkarzinom und kolonadenom - Google Patents

Verfahren zur untersuchung von kolonkarzinom und kolonadenom

Info

Publication number
DE602004029698D1
DE602004029698D1 DE602004029698T DE602004029698T DE602004029698D1 DE 602004029698 D1 DE602004029698 D1 DE 602004029698D1 DE 602004029698 T DE602004029698 T DE 602004029698T DE 602004029698 T DE602004029698 T DE 602004029698T DE 602004029698 D1 DE602004029698 D1 DE 602004029698D1
Authority
DE
Germany
Prior art keywords
colorectal
tissues
cancer
colorectal cancer
adenoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004029698T
Other languages
English (en)
Inventor
Reiji Kannagi
Mineko Izawa
Takashi Muramatsu
Kenji Uchimura
Hideaki Hosokawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOCAL GAVERNMENT OF AICHI PREF
Japan Science and Technology Agency
Fujifilm Wako Pure Chemical Corp
Original Assignee
LOCAL GAVERNMENT OF AICHI PREF
Wako Pure Chemical Industries Ltd
Japan Science and Technology Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOCAL GAVERNMENT OF AICHI PREF, Wako Pure Chemical Industries Ltd, Japan Science and Technology Agency filed Critical LOCAL GAVERNMENT OF AICHI PREF
Publication of DE602004029698D1 publication Critical patent/DE602004029698D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • G01N2333/91097Hexosyltransferases (general) (2.4.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004029698T 2003-08-20 2004-07-09 Verfahren zur untersuchung von kolonkarzinom und kolonadenom Active DE602004029698D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003296216A JP3805330B2 (ja) 2003-08-20 2003-08-20 大腸癌及び大腸腺腫の検査方法
PCT/JP2004/009805 WO2005019827A1 (ja) 2003-08-20 2004-07-09 大腸癌及び大腸腺腫の検査方法

Publications (1)

Publication Number Publication Date
DE602004029698D1 true DE602004029698D1 (de) 2010-12-02

Family

ID=34213585

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029698T Active DE602004029698D1 (de) 2003-08-20 2004-07-09 Verfahren zur untersuchung von kolonkarzinom und kolonadenom

Country Status (7)

Country Link
US (2) US7601348B2 (de)
EP (1) EP1674869B1 (de)
JP (1) JP3805330B2 (de)
AT (1) ATE485518T1 (de)
CA (1) CA2536328A1 (de)
DE (1) DE602004029698D1 (de)
WO (1) WO2005019827A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1605261B1 (de) 2003-03-19 2009-12-09 Hamamatsu Foundation for Science and Technology Promotion Verfahren zur erkennung eines kolonkrebsmarkers
JP4593295B2 (ja) 2005-01-19 2010-12-08 独立行政法人科学技術振興機構 癌及び腺腫の検査方法
JP2006284298A (ja) * 2005-03-31 2006-10-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 大腸腫瘍の診断方法
WO2007007792A1 (ja) * 2005-07-12 2007-01-18 Eisai R & D Management Co., Ltd. 抗体の検出法及び検出キット
EP1914318A4 (de) * 2005-08-10 2008-11-26 Hamamatsu Found Sci & Tech Pro Verfahren zum nachweis von dickdarmkrebsmarkern
CA2640429C (en) * 2006-01-27 2014-04-01 University Of Massachusetts Systems and methods for producing biofuels and related materials
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
CN107573414B (zh) * 2017-08-14 2020-08-07 李翀 人膀胱癌标志物ag-cd71及其抗体abc71和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0693A (ja) * 1992-04-23 1994-01-11 Otsuka Pharmaceut Co Ltd モノクローナル抗体
JPH0646878A (ja) * 1992-07-28 1994-02-22 Tosoh Corp モノクロ−ナル抗体およびその製造法
JP3809277B2 (ja) * 1998-03-05 2006-08-16 生化学工業株式会社 N−アセチルグルコサミン−6−o−硫酸基転移酵素のポリペプチド及びそれをコードするdna
US6365365B1 (en) 1998-03-20 2002-04-02 The Regents Of The University Of California Method of determining whether an agent modulates glycosyl sulfotransferase-3

Also Published As

Publication number Publication date
CA2536328A1 (en) 2005-03-03
WO2005019827A1 (ja) 2005-03-03
US7601348B2 (en) 2009-10-13
US20070196874A1 (en) 2007-08-23
JP3805330B2 (ja) 2006-08-02
JP2005062125A (ja) 2005-03-10
US20100015632A1 (en) 2010-01-21
EP1674869A1 (de) 2006-06-28
EP1674869B1 (de) 2010-10-20
EP1674869A4 (de) 2008-05-21
ATE485518T1 (de) 2010-11-15

Similar Documents

Publication Publication Date Title
Orphanou The detection and discrimination of human body fluids using ATR FT-IR spectroscopy
Zhao et al. Extracellular vesicles as cancer liquid biopsies: From discovery, validation, to clinical application
Bhati et al. Molecular characterization of human breast tumor vascular cells
Torra et al. Next-generation sequencing in adult B cell acute lymphoblastic leukemia patients
JP6455438B2 (ja) 固相デバイスにおける核酸の単離及び分析のためのラベルフリー方法
WO2005023091A3 (en) Method for non-invasive prenatal diagnosis
Devriese et al. Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
Vinarskaja et al. ID4 is frequently downregulated and partially hypermethylated in prostate cancer
Holtkötter et al. Independent validation of body fluid-specific CpG markers and construction of a robust multiplex assay
WO2014182598A1 (en) Diagnostic assay combining cellular and cell free nucleic acid
EP1930445A4 (de) Kit und verfahren zum nachweis von urothelkarzinom
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
CN110257525A (zh) 对肿瘤诊断具有显著性的标志物及其用途
DE602004029698D1 (de) Verfahren zur untersuchung von kolonkarzinom und kolonadenom
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
Chantepie et al. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia
Souza et al. Liquid biopsy in lung cancer: biomarkers for the management of recurrence and metastasis
US20150079033A1 (en) Detection of bladder cancer and recurrent bladder cancer
WO2009019369A3 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal
WO2006135775A3 (en) Rapid saccharide biomarker assay
Suijkerbuijk et al. Comparison of different promoter methylation assays in breast cancer
WO2009019366A3 (fr) Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal
Wu et al. Quantitative gene analysis of methylation and expression (Q‐GAME) in fresh or fixed cells and tissues
de Melo Rêgo et al. Immunohistochemiluminescence detection: A quantitative tool in breast cancer HER-2 status evaluation